|
1
|
Cork MJ, Danby SG, Vasilopoulos Y,
Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R
and Ward SJ: Epidermal barrier dysfunction in atopic dermatitis. J
Invest Dermatol. 129:1892–1908. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weidinger S and Novak N: Atopic
dermatitis. Lancet. 387:1109–1122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sidbury R and Hanifin JM: Old, new, and
emerging therapies for atopic dermatitis. Dermatol Clin. 18:1–11.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vender RB: Alternative treatments for
atopic dermatitis: A selected review. Skin Therapy Lett. 7:1–5.
2002.PubMed/NCBI
|
|
5
|
Gardiner P and Kemper KJ: Herbs in
pediatric and adolescent medicine. Pediatr Rev. 21:44–57. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yun Y, Kim K, Choi I and Ko SG: Topical
herbal application in the management of atopic dermatitis: A review
of animal studies. Mediators Inflamm. 2014:7521032014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quattrocchi U: CRC world dictionary of
medicinal and poisonous plants: Common names, scientific names,
eponyms, synonyms and etymology. CRC Press; Boca Raton: 2012,
View Article : Google Scholar
|
|
8
|
Lee YS, Kang MH, Cho SY and Jeong CS:
Effects of constituents of Amomum xanthioides on gastritis in rats
and on growth of gastric cancer cells. Arch Pharm Res. 30:436–443.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HG, Han JM, Lee JS and Son CG: Ethyl
acetate fraction of Amomum xanthioides improves bile duct
ligation-induced liver fibrosis of rat model via modulation of
pro-fibrogenic cytokines. Sci Rep. 5:145312015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SH and Shin TY: Amomum xanthiodes
inhibits mast cell-mediated allergic reactions through the
inhibition of histamine release and inflammatory cytokine
production. Exp Biol Med (Maywood). 230:681–687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SH, Lee S, Kim IK, Kwon TK, Moon JY,
Park WH and Shin TY: Suppression of mast cell-mediated allergic
reaction by Amomum xanthiodes. Food Chem Toxicol. 45:2138–2144.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi EJ, Lee S, Kim HH, Singh TS, Choi JK,
Choi HG, Suh WM, Lee SH and Kim SH: Suppression of dust mite
extract and 2,4-dinitrochlorobenzene-induced atopic dermatitis by
the water extract of Lindera obtusiloba. J Ethnopharmacol.
137:802–807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh TS, Lee S, Kim HH, Choi JK and Kim
SH: Perfluorooctanoic acid induces mast cell-mediated allergic
inflammation by the release of histamine and inflammatory
mediators. Toxicol Lett. 210:64–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JK and Kim SH: Inhibitory effect of
galangin on atopic dermatitis-like skin lesions. Food Chem Toxicol.
68:135–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Auriemma M, Vianale G, Amerio P and Reale
M: Cytokines and T cells in atopic dermatitis. Eur Cytokine Netw.
24:37–44. 2013.PubMed/NCBI
|
|
17
|
Choi JK, Oh HM, Lee S, Kwon TK, Shin TY,
Rho MC and Kim SH: Salvia plebeia suppresses atopic dermatitis-like
skin lesions. Am J Chin Med. 42:967–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Japan. Kōsei Rōdōshō. Nihon
yakkyokuhō=The Japanese pharmacopoeia. Kōsei Rōdōshō; Tokyo:
2001
|
|
19
|
Wang JH, Wang J, Choi MK, Gao F, Lee DS,
Han JM and Son CG: Hepatoprotective effect of Amomum xanthoides
against dimethylnitrosamine-induced sub-chronic liver injury in a
rat model. Pharm Biol. 51:930–935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guimarães AG, Quintans JS and Quintans LJ
Jr: Monoterpenes with analgesic activity-a systematic review.
Phytother Res. 27:1–15. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kawakami T, Ando T, Kimura M, Wilson BS
and Kawakami Y: Mast cells in atopic dermatitis. Curr Opin Immunol.
21:666–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stone KD, Prussin C and Metcalfe DD: IgE,
mast cells, basophils, and eosinophils. J Allergy Clin Immunol.
125(2 Suppl 2): S73–S80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitchell EB, Crow J, Williams G and
Platts-Mills TA: Increase in skin mast cells following chronic
house dust mite exposure. Br J Dermatol. 114:65–73. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujii Y, Takeuchi H, Sakuma S, Sengoku T
and Takakura S: Characterization of a
2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats.
Skin Pharmacol Physiol. 22:240–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yarbrough KB, Neuhaus KJ and Simpson EL:
The effects of treatment on itch in atopic dermatitis. Dermatol
Ther. 26:110–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Simon D, Braathen LR and Simon HU:
Eosinophils and atopic dermatitis. Allergy. 59:561–570. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu FT, Goodarzi H and Chen HY: IgE, mast
cells, and eosinophils in atopic dermatitis. Clin Rev Allergy
Immunol. 41:298–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adel-Patient K, Créminon C, Bernard H,
Clément G, Négroni L, Frobert Y, Grassi J, Wal JM and Chatel JM:
Evaluation of a high IgE-responder mouse model of allergy to bovine
beta-lactoglobulin (BLG): Development of sandwich immunoassays for
total and allergen-specific IgE, IgG1, and IgG2a in BLG-sensitized
mice. J Immunol Methods. 235:21–32. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brandt EB and Sivaprasad U: Th2 cytokines
and atopic dermatitis. Clin Dev Immunol. 2:pii: 1102011.
|
|
30
|
Zhu J, Yamane H and Paul WE:
Differentiation of effector CD4 T cell populations. Annu Rev
Immunol. 28:445–489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koga C, Kabashima K, Shiraishi N,
Kobayashi M and Tokura Y: Possible pathogenic role of Th17 cells
for atopic dermatitis. J Invest Dermatol. 128:2625–2630. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mansouri Y and Guttman-Yassky E: Immune
pathways in atopic dermatitis and definition of biomarkers through
broad and targeted therapeutics. J Clin Med. 4:858–873. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cornelissen C, Marquardt Y, Czaja K,
Wenzel J, Frank J, Lüscher-Firzlaff J, Lüscher B and Baron JM:
IL-31 regulates differentiation and filaggrin expression in human
organotypic skin models. J Allergy Clin Immunol. 129:426–433,
433.e1-8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raap U, Weißmantel S, Gehring M, Eisenberg
AM, Kapp A and Fölster-Holst R: IL-31 significantly correlates with
disease activity and Th2 cytokine levels in children with atopic
dermatitis. Pediatr Allergy Immunol. 23:285–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin H, He R, Oyoshi M and Geha RS: Animal
models of atopic dermatitis. J Invest Dermatol. 129:31–40. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Danso MO, van Drongelen V, Mulder A, van
Esch J, Scott H, van Smeden J and El Ghalbzouri A: TNF-α and Th2
cytokines induce atopic dermatitis-like features on epidermal
differentiation proteins and stratum corneum lipids in human skin
equivalents. J Invest Dermatol. 134:1941–1950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bossie A and Vitetta ES: IFN-gamma
enhances secretion of IgG2a from IgG2a-committed LPS-stimulated
murine B cells: Implications for the role of IFN-gamma in class
switching. Cell Immunol. 135:95–104. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Albanesi C, Cavani A and Girolomoni G:
IL-17 is produced by nickel-specific T lymphocytes and regulates
ICAM-1 expression and chemokine production in human keratinocytes:
Synergistic or antagonist effects with IFN-gamma and TNF-alpha. J
Immunol. 162:494–502. 1999.PubMed/NCBI
|
|
39
|
McGirt LY and Beck LA: Innate immune
defects in atopic dermatitis. J Allergy Clin Immunol. 118:202–208.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vestergaard C, Bang K, Gesser B, Yoneyama
H, Matsushima K and Larsen CG: A Th2 chemokine, TARC, produced by
keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional
atopic dermatitis skin. J Invest Dermatol. 115:640–646. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mizuno K, Morizane S, Takiguchi T and
Iwatsuki K: Dexamethasone but not tacrolimus suppresses
TNF-α-induced thymic stromal lymphopoietin expression in lesional
keratinocytes of atopic dermatitis model. J Dermatol Sci. 80:45–53.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang JH, Yoo JM, Cho WK and Ma JY:
Anti-inflammatory effects of Sanguisorbae Radix water extract on
the suppression of mast cell degranulation and STAT-1/Jak-2
activation in BMMCs and HaCaT keratinocytes. BMC Complement Altern
Med. 16:3472016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jung M, Lee TH, Oh HJ, Kim H, Son Y, Lee
EH and Kim J: Inhibitory effect of 5,6-dihydroergosteol-glucoside
on atopic dermatitis-like skin lesions via suppression of NF-κB and
STAT activation. J Dermatol Sci. 79:252–261. 2015. View Article : Google Scholar : PubMed/NCBI
|
